Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer

Completed · Phase 1

Conditions studied: Pancreatic Cancer

In brief

RATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to and kill tumor cells. Combining vaccine therapy with surgery may be an effective treatment for pancreatic cancer. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients with stage I or stage II pancreatic cancer that has been surgically removed.

Key facts

Study ID

NCT00003025

Run by

Memorial Sloan Kettering Cancer Center

People needed

16

Starts

1997-03-01

Expected to finish

2002-07-01

Last updated by the study team

2013-07-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.